Brain sites of movement disorder: Genetic and environmental agents in neurodevelopmental perturbations T. PalomoR. J. BeningerT. Archer OriginalPaper Pages: 1 - 26
Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease Manfred GerlachKay L. DoublePeter Riederer OriginalPaper Pages: 35 - 43
Neurobehavioural deficits following postnatal iron overload: I spontaneous motor activity A. FredrikssonN. SchröderT. Archer OriginalPaper Pages: 53 - 76
Neurobehavioural deficits following postnatal iron overload: II instrumental learning performance T. ArcherN. SchoröderA. Fredriksson OriginalPaper Pages: 77 - 94
Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment Trevor ArcherTomas PalomoAnders Fredriksson OriginalPaper Pages: 95 - 109
Dopamine receptor supersensitivity: An outcome and index of neurotoxicity Richard M. KostrzewaJohn P. KostrzewaRyszard Brus OriginalPaper Pages: 111 - 117
Neurotrophic factors for the investigation and treatment of movement disorders Justo Garcia De YébenesMarina SánchezMaria Angeles Mena OriginalPaper Pages: 119 - 137
Striatal glutamatergic mechanisms and extrapyramidal movement disorders Thomas N. ChaseFrancesco BibbianiJustin D. Oh OriginalPaper Pages: 139 - 145
A possible physiological role for cerebral tetrahydroisoquinolines Jerzy VetulaniLucyna Antkiewicz-MichalukMario Sansone OriginalPaper Pages: 147 - 155
Axonal degeneration and progressive neurologic disability in multiple sclerosis Carl BjartmarBruce D. Trapp OriginalPaper Pages: 157 - 164
